Recombinant Mouse Lymphocyte antigen 6A-2/LY6A Protein，His & Myc

Lymphocyte antigen 6A-2 (LY6A) is a member of the LY6 family of glycosylphosphatidylinositol (GPI)-anchored proteins, which play critical roles in immune response regulation and hematopoiesis. LY6A is predominantly expressed in lymphocytes, particularly in T cells and hematopoietic stem cells, and is involved in various cellular functions, including cell adhesion, signaling, and differentiation. The study of LY6A as a recombinant protein has gained traction due to its potential implications in immunotherapy, cancer biology, and regenerative medicine. Research has shown that LY6A can serve as a marker for specific immune cell populations, aiding in the identification and characterization of T cell subsets in both health and disease states. Moreover, its expression patterns have been correlated with tumor microenvironments, making it a candidate for novel cancer therapies targeting LY6A-expressing cells. The ability to produce LY6A as a recombinant protein allows for detailed functional studies and the exploration of its mechanisms in immune modulation. Understanding the interactions of LY6A with other cellular proteins and its involvement in immune evasion strategies by tumors could lead to breakthroughs in therapeutic approaches for cancer and autoimmune disorders. As such, LY6A represents a pivotal target for both basic and translational research in immunology and oncology, underpinning the need for further investigation into its biological functions and clinical relevance.